Menu
Back to Journals » International Journal of Nanomedicine » Volume 13
Original Research
Transferrin receptor-targeted HMSN for sorafenib delivery in refractory differentiated thyroid cancer therapy
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 6,714 | Dovepress* | 5,792+ | 1,120 | 6,912 | |
| PubMed Central* | 922 | 286 | 1,208 | ||
| Totals | 6,714 | 1,406 | 8,120 | ||
| *Since 6 December 2018 | |||||
View citations on PubMed Central and Google Scholar